Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/14/24 08:45 | 9/8/23 | CRMD | Health | Drug | Pharmaceutical Preparations | Todisco Joseph | NJ | DO | CEO | 3 | P.a | 111 | 3.88 | 0 | 29 | 9 | 353 | D | ||||||||||||||
12/18/23 16:47 | 12/14/23 | CRMD | Health | Drug | Pharmaceutical Preparations | Dunton Alan W | NJ | D | 2 | P.am | 33 | 3.69 | 0 | 9 | 144 | 15 | D | |||||||||||||||
11/21/23 16:00 | 11/17/23 | CRMD | Health | Drug | Pharmaceutical Preparations | Mistry Erin | NJ | O | Chief Co | 1 | P | 4 | 4.00 | 0 | 1 | 26 | 5 | D | ||||||||||||||
5/19/23 16:02 | 5/18/23 | CRMD | Health | Drug | Pharmaceutical Preparations | Kaplan Myron | NJ | D | 1 | P | 27 | 4.54 | 0 | 6 | 3 | 196 | D | |||||||||||||||
5/18/23 18:26 | 5/17/23 | CRMD | Health | Drug | Pharmaceutical Preparations | Costa Paulo F | NJ | D | 1 | P.a | 47 | 4.65 | 0 | 10 | 10 | D | ||||||||||||||||
5/18/23 16:51 | 5/17/23 | CRMD | Health | Drug | Pharmaceutical Preparations | Stewart Robert A | NJ | D | 1 | P.a | 44 | 4.37 | 0 | 10 | 999% | 11 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |